Organized by AIChE’s Society for Biological Engineering (SBE), the 8th International Conference on Accelerating Biopharmaceutical Development will be held September 6-8, 2023 in The Royal Sonesta Boston, Cambridge, MA.
Hear from AccBio Conference keynote speaker Raymond Deshaies about the future of biopharmaceutical development.
This award is presented to individuals or teams exhibiting exceptional leadership in industries served by chemical engineers.
Wondering what others are talking about? Check out the latest technical and career discussions on AIChE Engage.
Suddenly, synthetic biology is being discussed a lot beyond the walls of academia and the pages of scientific journals. Today, it abounds in the mainstream press.
The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.
Jacob Albrecht discusses the challenging but enjoyable road to manufacturing new medicines, and the creative aspects of process engineering.
Hear Ryan's perspective on what advances he thinks chemical engineering has ahead of it.
Humans have roughly 40 trillion bacterial cells in their bodies; up to 1,000 species of bacteria live in the human gut alone.
A look at the future of chemical engineering from the perspective of pharmaceutical manufacturing.
Process engineers are bringing improved manufacturing to the pharmaceuticals industry. Read one process engineer's take on her work in the industry.
UCLA biochemists have harnessed cryo-electron microscopy to see near-atomic detail in much smaller proteins than ever before.
Microorganisms have long been used to help humans carry out various processes such as brewing and the production of antibiotics, but these processes remain very complex, with bioreactors seen as “b
A new experimental broad-spectrum antiviral drug could be used to combat the type of virus that causes the common cold and pneumonia, as well as more lethal viruses such as SARS and MERS.
A new report released by the European Centre for Disease Prevention and control (ECDC) emphasizes that antimicrobial resistance remains one of the greatest public health threats today.
An international team of researchers has created new antiviral nanoparticles that show potential for outperforming current antiviral drugs.
New imagine of a key protein's signaling mechanism provides insights for better pharmaceuticals.
The device aims to test and predict the effects of biological and chemical agents, diseases, or drugs on the brain without the need for human or animal subjects.
A new technique labels gene segments to help understand how the virus enters a cell and establishes co-infections.
In its first year, BioTM is already topping the charts, with top ratings for viewing, sharing, and discussion of articles.
The failure rate for new drugs and therapies under development exceeds 95%.
A compound found in a snail's venom yields pain-fighting effects in testing, presenting a possible opioid alternative.
Using nanostraws, scientists can now sample cell contents without disrupting a cell's natural processes.
As we approach ICBE 2017, which begins this weekend in San Diego, we look back at some of the exciting research that figured among 2016's highlights and look forward to the new developments to be unveiled at ICBE 2017.
Researchers at the University of Michigan have had a significant breakthrough in creating a customized therapeutic vaccine for treating colon and melanoma cancer tumors in mice.
Researchers at the University of California, Riverside, recently published work that suggests that the usefulness of studying pro- and anti-apoptotic proteins in a search for cancer
The 2016 D.I.C.
Tests by researchers at Baylor College of Medicine have recently shown that nanoparticles modified with polyethylene glycol selectively affect specific areas of the immune system, showing potential
A startup in southern California is designing microbes that extend DNA beyond the natural A, T, G, and C components to include X and Y.
It sounds like something straight out of a science fiction movie: bacteria that feeds on human flesh.
The U.S. government announced this week that it is putting aside $55 million to create a public database with health information on about one million volunteers.
AccBio 2015 is a four-day conference focusing on scientific, technical, business and regulatory advances in the field of biopharmaceutical development.
“Meeting Current Challenges in Therapeutic Protein Technical Development” is the theme of SBE's 3rd International Conference on Accelerating Biopharmaceutical Development & Quality by Design in Biologics (QbD).
